Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
08/2013
08/14/2013CN103249721A Arylamide derivatives as TTX-S blockers
08/14/2013CN103242303A Afatinib preparation method
08/14/2013CN103242302A Preparation method of lapatinib
08/14/2013CN103242301A 5-hydrogenation benzopyran substituted pyrimidine carbocyclic ring nucleoside and preparation method
08/14/2013CN103242273A 2-arylbenzofuran-7-methanamide compound, preparation method and application thereof
08/14/2013CN103242234A Pyrazole synthesis by coupling of carboxylic acid derivatives and enamines
08/14/2013CN103242218A N-substituted pipecolic acid derivative, as well as preparation method and application thereof
08/14/2013CN102276576B Benzamide compound and preparation method thereof
08/14/2013CN101945879B Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
08/14/2013CN101743229B Quinazolinamide derivatives
08/14/2013CN101730689B pigmentation-regulator compound
08/14/2013CN101490038B Pyrimidine derivatives as ALK-5 inhibitors
08/14/2013CN101486682B N3 alkylated benzimidazole derivatives as MEK inhibitors
08/13/2013US8507687 Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
08/13/2013US8507534 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
08/13/2013US8507521 Heterocyclic derivatives
08/13/2013CA2554782C Methods to manufacture 1,3-dioxolane nucleosides
08/08/2013WO2013116182A1 Heterocyclic compounds as inhibitors of leukotriene production
08/08/2013WO2013115486A1 Novel piperine derivative and use therefor
08/08/2013WO2013114338A1 Process for the preparation of vilazodone or its pharmaceutically acceptable salts
08/08/2013US20130204011 Pyrazole synthesis by coupling of carboxylic acid derivatives and enamines
08/08/2013US20130203994 Preparation of posaconazole intermediates
08/08/2013US20130203993 Process for the preparation of chiral hydrazides
08/08/2013US20130203991 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
08/08/2013US20130203987 Ampk-activating heterocyclic compounds and methods for using the same
08/08/2013US20130203818 Compounds that modulate intracellular calcium
08/08/2013US20130203816 Prolyl hydroxylase inhibitors and methods of use
08/08/2013US20130203815 Cytokine inhibitors
08/08/2013US20130203775 Novel Compounds for the Treatment of Hepatitis C
08/08/2013US20130203767 Treatment of Pulmonary Hypertension
08/08/2013US20130203758 Compounds for the Treatment of Hepatitis C
08/08/2013US20130203750 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
08/08/2013US20130203747 Inhibitors of human immunodeficiency virus replication
08/08/2013US20130203728 Pyrrolidine compounds
08/08/2013US20130203709 Acylsulfonamides and processes for producing the same
08/08/2013US20130203656 Inhibitors of hcv ns5a
08/08/2013US20130203593 Pesticidal compositions and processes related thereto
08/08/2013US20130203592 Pesticidal compositions and processes related thereto
08/08/2013US20130202573 Thioacetate compounds, compositions and methods of use
08/07/2013EP2623503A1 Chromene derivatives
08/07/2013EP2623502A1 Novel compound having strigolactone-like activity and use thereof
08/07/2013EP2623491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
08/07/2013EP2621922A1 A process for the synthesis of thio-triazolo-group containing compounds
08/07/2013EP2621916A1 Benzazole derivatives as histamine h4 receptor ligands
08/07/2013EP2621904A2 Compounds as c-met kinase inhibitors
08/07/2013CN103237800A Amide derivative and use thereof
08/07/2013CN103237797A Quinolin-4 (1h)-ketone derivatives as inhibitors of phosphatidylinositol 3-kinases
08/07/2013CN103232843A Electroluminescent material and application thereof
08/07/2013CN103232439A N-heterocyclic methyl tetrahydropyridine-5-substituted indole and preparation method and application thereof
08/07/2013CN102277154B Phenyl piperazine small-molecule fluorescent probe of alpha1-adrenergic receptor and application thereof
08/07/2013CN101622234B Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
08/06/2013US8501787 Compounds for the inhibition of angiogenesis and use thereof
08/06/2013US8501784 2-pyridone derivatives as neutrophil elastase inhibitors and their use
08/06/2013US8501782 Piperidinyl derivatives as modulators of chemokine receptor activity
08/06/2013US8501777 3,5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission
08/06/2013US8501773 4-fluoro-piperidine T-type calcium channel antagonists
08/06/2013US8501740 Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors
08/06/2013US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
08/06/2013CA2752421C Amino ester derivatives, salts thereof and methods of use
08/06/2013CA2751901C Mineralocorticoid receptor antagonist and methods of use
08/06/2013CA2588513C 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/06/2013CA2560653C Angiogenesis inhibitors and uses thereof
08/01/2013WO2013112804A1 Formulations of 3-(6-(1-(2.2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
08/01/2013WO2013111850A1 Chromone derivative having osteogenesis promoting effect
08/01/2013WO2013111107A1 Aminopyridine derivatives as plasma kallikrein inhibitors
08/01/2013WO2013110433A1 Azaheterocyclic compounds
08/01/2013WO2010120994A3 Ureidoaryl-and carbamoylaryl-morpholino- pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis
08/01/2013US20130197034 Salts Of Methyl 2-((R)-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3-((R)-Tetrahydro-2H-Pyran-3-Yl)Propylcarbamoyl)Piperidin-3-Yl)Methoxy)Ethylcarbamate
08/01/2013US20130197033 Paroxetine derivative
08/01/2013US20130197030 Substituted 1,3-Dioxanes and There Uses
08/01/2013US20130197013 Cyclopropylamine derivatives useful as lsd1 inhibitors
08/01/2013US20130196990 Benzimidazole Derivatives As PI3 Kinase Inhibitors
08/01/2013US20130196987 Macrocyclic compounds useful as pharmaceuticals
08/01/2013US20130196975 5-alkynyl-pyridines
08/01/2013US20130196973 Benzodioxane inhibitors of leukotriene production
08/01/2013US20130196971 Fatty acid synthase inhibitors
08/01/2013US20130196967 Heterocyclic compounds as inhibitors of leukotriene production
07/2013
07/31/2013EP2620435A1 Phenyl and benzodioxinyl substituted indazole derivatives
07/31/2013EP2620429A1 Hydroxylamine compounds and methods of their use
07/31/2013EP2619178A1 Substituted benzamide compounds
07/31/2013CN103228650A A process for the synthesis of thio-riazolo-group containing compounds
07/31/2013CN103228643A Benzazole derivatives as histamine H4 receptor ligands
07/31/2013CN103228141A Substituted fused pyrimidinones and dihydropyrimidinones
07/31/2013CN103224490A Rosuvastatin and atorvastatin derivatives
07/31/2013CN103224466A Compound with beta-secretase inhibition function, its preparation method and application
07/31/2013CN101863883B Piperidone azine compound with activity of resisting leukemia K562 cell proliferation and preparation method thereof
07/31/2013CN101663293B Quinoline-carboxamide derivatives as p2y12 antagonists
07/30/2013US8497376 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent
07/30/2013US8497361 Topoisomerase binding probe and method of use
07/30/2013US8497301 Hydroxyl compounds and compositions for cholesterol management and related uses
07/30/2013US8497292 Translational dysfunction based therapeutics
07/30/2013CA2659549C Compositions and methods relating to novel compounds and targets thereof
07/30/2013CA2626103C 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides
07/30/2013CA2599538C N-sulphonylpyrroles and their use as histone deacetylase inhibitors
07/30/2013CA2561305C Tetrahydro-indazole cannabinoid modulators
07/30/2013CA2547410C 1,2,3-triazole amide derivatives as inhibitors of cytokie production
07/25/2013WO2013109882A1 Substituted pyrimidine compounds and their use as syk inhibitors
07/25/2013WO2013109859A1 Dye compositions, methods of preparation, conjugates thereof, and methods of use
07/25/2013WO2013109045A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
07/25/2013WO2013108921A1 Industrial process for preparation of 1,2-dihydroquinoline derivative or a salt thereof, and intermediate for preparation thereof
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 694